Metraipolis › archive › dc_281f870df145
Ceftazidime-avibactam for multidrug-resistant gram-negative infections: outcomes and timing of initiation across 22 U.S. medical centers — Europe PMC PMID:42138697
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42138697
- DOI
- 10.1128/aac.00268-26
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T07:22:50.329Z
- SHA-256 of the archived text
1897091c7d4f54913334b89dc9d73791a47edb62e3b608e4c909a1ad4723407a- Stable URL of this page
https://metraipolis.com/documento/dc_281f870df145
How to cite
Ceftazidime-avibactam for multidrug-resistant gram-negative infections: outcomes and timing of initiation across 22 U.S. medical centers — Europe PMC PMID:42138697 — Europe PMC (en), https://europepmc.org/article/MED/42138697 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_281f870df145 (Metraipolis archive dc_281f870df145, sha256 1897091c7d4f54913334b89dc9d73791a47edb62e3b608e4c909a1ad4723407a)
BibTeX
@misc{dc281f870df145,
title = {Ceftazidime-avibactam for multidrug-resistant gram-negative infections: outcomes and timing of initiation across 22 U.S. medical centers — Europe PMC PMID:42138697},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42138697},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_281f870df145; sha256 1897091c7d4f54913334b89dc9d73791a47edb62e3b608e4c909a1ad4723407a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42138697. Agents can read the archived copy with the MCP tool read_document.